Porous silicon advances in drug delivery and immunotherapy

Current Opinion in Pharmacology

Volumn 13, Issue 5, 2013, Pages 834-841

  Savage, David J ^a,b,c   Liu, Xuewu ^a   Curley, Steven A ^b   Ferrari, Mauro ^a   Serda, Rita E ^a  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREMOPHOR; DAUNORUBICIN; DIOLEOYLPHOSPHATIDYLCHOLINE; DOXORUBICIN; EPHRIN RECEPTOR A2; IMMUNOLOGICAL ADJUVANT; LIPOSOME; MACROGOL; NANOWIRE; PACLITAXEL; SILICON; SILICON DIOXIDE; SMALL INTERFERING RNA;

ANTIGEN PRESENTING CELL; ARTICLE; BREAST CANCER; CELL TRANSPORT; CONTROLLED DRUG RELEASE; DEGRADATION; DENDRITIC CELL; DISSOLUTION; DRUG DELIVERY SYSTEM; GENE SILENCING; IMMUNOTHERAPY; MICELLE; NONHUMAN; ONCOGENE; OVARY CANCER; PH; PRIORITY JOURNAL; SURFACE PROPERTY; SUSTAINED DRUG RELEASE;

ANIMALS; ANTINEOPLASTIC AGENTS; BLOOD PROTEINS; DRUG DELIVERY SYSTEMS; IMMUNOTHERAPY; NEOPLASMS; POROSITY; SILICON; SOLUBILITY;

EID: 84892968806     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2013.06.006     Document Type: Review

References (50)

1. Tsang CK, Kelly TL, Sailor MJ, Li YY: Highly stable porous silicon - carbon composites as label-free optical biosensors. ACS Nano 2012, 6: 10546-10554.
2. Uhlir A: Electrolytic Shaping of Germanium and Silicon, 1956, March, JBSTJ, 35:2: 333-347.
3. Canham LT: Silicon quantum wire array fabrication by electrochemcal and chemical dissolutions of wafers. Appl Phys Lett 1990, 57: 1046-1048.
4. Lehmann V, Gosele U: Porous silicon formation - a quantum wire effect. Appl Phys Lett 1991, 58: 856-858.
5. Sailor MF: Porous Silicon in Practice: Preparation, Characterization, and Applications. edn 1. Wiley-VCH Verlag GmbH & Co. KGaA; 2012:: 1-42.
6. Park JH, Gu L, von Maltzahn G, Ruoslahti E, Bhatia SN, Sailor MJ: Biodegradable luminescent porous silicon nanoparticles for in vivo applications. Nat Mater 2009, 8: 331-336.
7. Godin B, Gu J, Serda RE, Bhavane R, Tasciotti E, Chiappini C, Liu X, Tanaka T, Decuzzi P, Ferrari M: Tailoring the degradation kinetics of mesoporous silicon structures through pegylation. J Biomed Mater Res A 2010, 94: 1236-1243.
8. Canham LT: INSPEC (Information Service): Properties of Porous Silicon. London: INSPEC; 1987,.
9. Tasciotti E, Liu X, Bhavane R, Plant K, Leonard AD, Price BK, Cheng MM, Decuzzi P, Tour JM, Robertson F, Ferrari M: Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. Nat Nanotechnol 2008, 3: 151-157. (Pubitemid 351355132)
10. Chiappini C, Tasciotti E, Fakhoury J, Fine D, Pullan L, Wang Y, Fu L, Liu X, Ferrari M: Tailored porous silicon microparticles: fabrication and properties. ChemPhysChem 2010, 11: 1029-1035.
11. Godin B, Chiappini C, Srinivasan S, Alexander J, Yokoi K, Ferrari M, Decuzzi P, Liu X: Discoidal porous silicon particles: fabrication and biodistribution in breast cancer bearing mice. Adv Funct Mater 2012, 22: 4225-4235.
12. Park JS, Meade SO, Segal E, Sailor MJ: Porous silicon-based polymer replicas formed by bead patterning. Phys Status Solidi A 2007, 204: 1383-1387. (Pubitemid 47119996)
13. Ghiringhelli F, Puig PE, Roux S, Parcellier A, Schmitt E, Solary E, Kroemer G, Martin F, Chauffert B, Zitvogel L: Tumor cells convert immature myeloid dendritic cells into tgf-beta-secreting cells inducing cd4+cd25+ regulatory t cell proliferation. J Exp Med 2005, 202: 919-929. (Pubitemid 41396892)
14. Ryckman JD, Liscidini M, Sipe JE, Weiss SM: Direct imprinting of porous substrates: a rapid and low-cost approach for patterning porous materials. Nano Lett 2010, 11: 1857-1862.
15. Chiappini C, Liu X, Fakhoury JR, Ferrari M: Biodegradable porous silicon barcode nanowires with defined geometry. Adv Funct Mater 2010, 20: 2231-2239.
16. Hochbaum AI, Gargas D, Hwang YJ, Yang P: Single crystalline mesoporous silicon nanowires. Nano Lett 2009, 9: 3550-3554.
17. Qu Y, Liao L, Li Y, Zhang H, Huang Y, Duan X: Electrically conductive and optically active porous silicon nanowires. Nano Lett 2009, 9: 4539-4543.
18. Wattendorf U, Merkle HP: Pegylation as a tool for the biomedical engineering of surface modified microparticles. J Pharm Sci 2008, 97: 4655-4669.
19. Ishihara T, Takeda M, Sakamoto H, Kimoto A, Kobayashi C, Takasaki N, Yuki K, Tanaka KI, Takenaga M, Igarashi R, Maeda T et al.: Accelerated blood clearance phenomenon upon repeated injection of peg-modified pla-nanoparticles. Pharm Res Dord 2009, 26: 2270-2279.
20. Canham LT: Bioactive silicon structure fabrication through nanoetching techniques. Adv Mater 1995, 7:1033.
21. Serda RE, Blanco E, Mack A, Stafford SJ, Amra S, Li Q, van de Ven A, Tanaka T, Torchilin VP, Wiktorowicz JE, Ferrari M: Proteomic analysis of serum opsonins impacting biodistribution and cellular association of porous silicon microparticles. Mol Imaging 2011, 10: 43-55.
22. Walczyk D, Bombelli FB, Monopoli MP, Lynch I, Dawson KA: What the cell 'sees' in bionanoscience. J Am Chem Soc 2010, 132: 5761-5768.
23. Serda RE, Gu J, Bhavane RC, Liu X, Chiappini C, Decuzzi P, Ferrari M: The association of silicon microparticles with endothelial cells in drug delivery to the vasculature. Biomaterials 2009, 30: 2440-2448.
24. Serda RE, Gu J, Burks JK, Ferrari K, Ferrari C, Ferrari M: Quantitative mechanics of endothelial phagocytosis of silicon microparticles. Cytometry A: J Int Soc Anal Cytol 2009, 75: 752-760.
25. Ferrati S, Shamsudeen S, Summers HD, Rees P, Abbey JV, Schmulen J, Liu X, Wong ST, Bean AJ, Ferrari M, Serda RE: Inter-endothelial transport of microvectors using cellular shuttles and tunneling nanotubes. Small 2012, 8: 3151-3160.
26. Serda RE, Godin B, Blanco E, Chiappini C, Ferrari M: Multi-stage delivery nano-particle systems for therapeutic applications. Biochim Biophys Acta 2011, 1810: 317-329.
27. Decuzzi P, Ferrari M: The receptor-mediated endocytosis of nonspherical particles. Biophys J 2008, 94: 3790-3797.
28. Serda RE, Mack A, Pulikkathara M, Zaske AM, Chiappini C, Fakhoury JR, Webb D, Godin B, Conyers JL, Liu XW, Bankson JA et al.: Cellular association and assembly of a multistage delivery system. Small 2010, 6: 1329-1340.
29. Godin B, Tasciotti E, Liu X, Serda RE, Ferrari M: Multistage nanovectors: from concept to novel imaging contrast agents and therapeutics. Acc Chem Res 2011, 44: 979-989.
30. Serda RE, Mack A, van de Ven AL, Ferrati S, Dunner K Jr, Godin B, Chiappini C, Landry M, Brousseau L, Liu X, Bean AJ et al.: Logic-embedded vectors for intracellular partitioning, endosomal escape, and exocytosis of nanoparticles. Small 2010, 6: 2691-2700.
31. van de Ven AL, Kim P, Haley O, Fakhoury JR, Adriani G, Schmulen J, Moloney P, Hussain F, Ferrari M, Liu X, Yun SH et al.: Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution. J Control Release 2012, 158: 148-155.
32. Mann AP, Bhavane RC, Somasunderam A, Liz Montalvo-Ortiz B, Ghaghada KB, Volk D, Nieves-Alicea R, Suh KS, Ferrari M, Annapragada A, Gorenstein DG et al.: Thioaptamer conjugated liposomes for tumor vasculature targeting. Oncotarget 2011, 2: 298-304.
33. Tanaka T, Mangala LS, Vivas-Mejia PE, Nieves-Alicea R, Mann AP, Mora E, Han HD, Shahzad MM, Liu X, Bhavane R, Gu J et al.: Sustained small interfering RNA delivery by mesoporous silicon particles. Cancer Res 2010, 70: 3687-3696.
34. Shen H, Rodriguez-Aguayo C, Xu R, Gonzalez-Villasana V, Mai J, Huang Y, Zhang G, Guo X, Bai L, Qin G, Deng X et al.: Enhancing chemotherapy response with sustained epha2 silencing using multistage vector delivery. Clin Cancer Res: Off J Am Assoc Cancer Res 2013, 19: 1806-1815.
35. Duncan R, Gaspar R: Nanomedicine(s) under the microscope. Mol Pharm 2011, 8: 2101-2141.
36. Blanco E, Sangai T, Hsiao A, Ferrati S, Bai L, Liu X, Meric-Bernstam F, Ferrari M: Multistage delivery of chemotherapeutic nanoparticles for breast cancer treatment. Cancer Lett 2012.
37. Chhablani J, Nieto A, Hou H, Wu EC, Freeman WR, Sailor MJ, Cheng L: Oxidized porous silicon particles covalently grafted with daunorubicin as a sustained intraocular drug delivery system. Invest Ophthal Vis Sci 2013, 54: 1268-1279.
38. Ma M, Chen H, Chen Y, Wang X, Chen F, Cui X, Shi J: Au capped magnetic core/mesoporous silica shell nanoparticles for combined photothermo-/chemo- therapy and multimodal imaging. Biomaterials 2012, 33: 989-998.
39. Thomas CR, Ferris DP, Lee JH, Choi E, Cho MH, Kim ES, Stoddart JF, Shin JS, Cheon J, Zink JI: Noninvasive remote- controlled release of drug molecules in vitro using magnetic actuation of mechanized nanoparticles. J Am Chem Soc 2010, 132: 10623-10625.
40. Liu Q, Zhang J, Xia W, Gu H: Towards magnetic-enhanced cellular uptake, MRI and chemotherapeutics delivery by magnetic mesoporous silica nanoparticles. J Nanosci Nanotechnol 2012, 12: 7709-7715.
41. Chen AM, Zhang M, Wei D, Stueber D, Taratula O, Minko T, He H: Co-delivery of doxorubicin and bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells. Small 2009, 5: 2673-2677.
42. Hu X, Hao X, Wu Y, Zhang J, Zhang X, Wang PC, Zou G, Liang XJ: Multifunctional hybrid silica nanoparticles for controlled doxorubicin loading and release with thermal and pH dually response. J Mater Chem B: Mater Biol Med 2013, 1: 1109-1118.
43. Blanco E, Hsiao A, Ruiz-Esparza GU, Landry MG, Meric-Bernstam F, Ferrari M: Molecular-targeted nanotherapies in cancer: enabling treatment specificity. Mol Oncol 2011, 5: 492-503.
44. Meraz IM, Melendez B, Gu J, Wong ST, Liu X, Andersson HA, Serda RE: Activation of the inflammasome and enhanced migration of microparticle- stimulated dendritic cells to the draining lymph node. Mol Pharm 2012.
45. Serda RE: Particle platforms for cancer immunotherapy. Int J Nanomed 2013, 8: 1-14.
46. Gu L, Ruff LE, Qin Z, Corr M, Hedrick SM, Sailor MJ: Multivalent porous silicon nanoparticles enhance the immune activation potency of agonistic cd40 antibody. Adv Mater 2012, 24: 3981-3987.
47. Little SR: Reorienting our view of particle-based adjuvants for subunit vaccines. Proc Natl Acad Sci U S A 2012, 109: 999-1000.
48. Baumgartner CK, Malherbe LP: Regulation of cd4 t-cell receptor diversity by vaccine adjuvants. Immunology 2010, 130: 16-22.
49. Hong C, Lee J, Zheng H, Hong SS, Lee C: Porous silicon nanoparticles for cancer photothermotherapy. Nanoscale Res Lett 2011, 6:321.
50. Serda RE, Ferrati S, Godin B, Tasciotti E, Liu X, Ferrari M: Mitotic trafficking of silicon microparticles. Nanoscale 2009, 1: 250-259.